Figure 8.
(A) Alteration of RTK-RAS pathway in GBC cohort. (B) Alteration of WNT pathway in GBC cohort. (C) Alteration of PI3K pathway in GBC cohort. (D) Alteration of NOTCH pathway in GBC cohort. (E) Alteration of TP53 pathway in GBC cohort. (F) Alteration of Hippo pathway in GBC cohort. (G) Alteration of MYC pathway in GBC cohort. (H) Alteration of Cell_Cycle pathway in GBC cohort. (I) Alteration of TGF-Beta pathway in GBC cohort. The color intensity represented the alteration frequency of pathway members. An arrow indicated an activation; without an arrow represented the binding activity; a bar at the end of an edge indicated an inhibitory interaction.